• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of Non-alcoholic Fatty Liver Disease among Patients with Diabetes Mellitus Attending Primary Health Care Centers in Bahrain.巴林初级卫生保健中心糖尿病患者中非酒精性脂肪性肝病的患病率
Oman Med J. 2022 Mar 22;37(2):e350. doi: 10.5001/omj.2022.53. eCollection 2022 Mar.
2
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
3
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。
Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.
4
Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.非酒精性脂肪性肝病合并糖尿病患者的纤维化患病率、特征及相关因素
Acta Med Indones. 2017 Apr;49(2):91-98.
5
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
6
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
7
Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.2型糖尿病人群中根据脂肪肝指数定义的非酒精性脂肪性肝病的患病率及预测因素
Clujul Med. 2016;89(1):82-8. doi: 10.15386/cjmed-544. Epub 2016 Jan 15.
8
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.非酒精性脂肪性肝病与 2 型糖尿病的微血管并发症。
World J Gastroenterol. 2013 May 28;19(20):3134-42. doi: 10.3748/wjg.v19.i20.3134.
9
Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease.2型糖尿病合并非酒精性脂肪性肝病患者的肝酶升高
Cureus. 2018 Nov 23;10(11):e3626. doi: 10.7759/cureus.3626.
10
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].[非酒精性脂肪性肝病增加2型糖尿病发病率:一项基于苏南某乡镇老年人群的队列研究]
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223.

引用本文的文献

1
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴一家三级医院对2型糖尿病患者的非酒精性脂肪性肝病评估。
J Diabetes Res. 2025 Aug 23;2025:5555842. doi: 10.1155/jdr/5555842. eCollection 2025.
2
The Rising Burden of Fatty Liver Disease in the Middle East: Why Oman Must Act Now?中东地区脂肪肝疾病负担日益加重:阿曼为何必须立即行动?
Oman Med J. 2025 Jan 31;40(1):e707. doi: 10.5001/omj.2025.90. eCollection 2025 Jan.
3
Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease.评估非酒精性脂肪性肝病风险因素的多管齐下方法。
Oman Med J. 2022 Sep 30;37(5):e425. doi: 10.5001/omj.2022.93. eCollection 2022 Sep.

本文引用的文献

1
Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者非酒精性脂肪性肝病的影响:随机临床试验的系统评价与荟萃分析及试验序贯分析
Oman Med J. 2021 May 31;36(3):e273. doi: 10.5001/omj.2021.62. eCollection 2021 May.
2
Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits.非酒精性脂肪性肝病中的肌少症性肥胖——两种致病因素的结合
Life (Basel). 2021 Feb 4;11(2):119. doi: 10.3390/life11020119.
3
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.美国非酒精性脂肪性肝病的流行病学、新兴药物治疗、肝移植影响及趋势
J Clin Transl Hepatol. 2020 Jun 28;8(2):215-221. doi: 10.14218/JCTH.2020.00014. Epub 2020 May 29.
4
Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study.印度2型糖尿病和高血压患者甲状腺功能减退症的患病率:一项横断面观察性研究。
Diabetes Metab Syndr Obes. 2019 Mar 20;12:369-376. doi: 10.2147/DMSO.S181470. eCollection 2019.
5
Selection Bias When Estimating Average Treatment Effects Using One-sample Instrumental Variable Analysis.使用单一样本工具变量分析估计平均处理效应时的选择偏差。
Epidemiology. 2019 May;30(3):350-357. doi: 10.1097/EDE.0000000000000972.
6
Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.沙特阿拉伯西南部阿巴市 2 型糖尿病患者中的非酒精性脂肪性肝病。
Int J Environ Res Public Health. 2018 Nov 11;15(11):2521. doi: 10.3390/ijerph15112521.
7
Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.超声肝脏脂肪变性程度与代谢综合征风险独立相关。
Can J Gastroenterol Hepatol. 2018 Aug 23;2018:8490242. doi: 10.1155/2018/8490242. eCollection 2018.
8
Diabesity in the Arabian Gulf: Challenges and Opportunities.阿拉伯湾地区的糖尿病肥胖症:挑战与机遇
Oman Med J. 2018 Jul;33(4):273-282. doi: 10.5001/omj.2018.53.
9
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.非酒精性脂肪性肝病与 2 型糖尿病发病风险:荟萃分析。
Diabetes Care. 2018 Feb;41(2):372-382. doi: 10.2337/dc17-1902.
10
Non-alcoholic Fatty Liver Disease: A Clinical Update.非酒精性脂肪性肝病:临床最新进展
J Clin Transl Hepatol. 2017 Dec 28;5(4):384-393. doi: 10.14218/JCTH.2017.00013. Epub 2017 Jul 26.

巴林初级卫生保健中心糖尿病患者中非酒精性脂肪性肝病的患病率

Prevalence of Non-alcoholic Fatty Liver Disease among Patients with Diabetes Mellitus Attending Primary Health Care Centers in Bahrain.

作者信息

Mohamed Afaf Merza, Isa Hasan Mohamed, Ali Mohamed Shaikh, Dadi Abdulhusain, Kadhim Zahra

机构信息

Public Health Directorate, Ministry of Health, Manama, Bahrain.

Pediatric Department, Salmaniya Medical Complex, Ministry of Health, Manama, Bahrain.

出版信息

Oman Med J. 2022 Mar 22;37(2):e350. doi: 10.5001/omj.2022.53. eCollection 2022 Mar.

DOI:10.5001/omj.2022.53
PMID:35356372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8941014/
Abstract

OBJECTIVES

To identify the prevalence of non-alcoholic fatty liver disease (NAFLD) among patients with type 2 diabetes mellitus (T2DM) in Bahrain and to assess the risk factors for the same.

METHODS

This retrospective cross-sectional study investigated a random sample of patients who were treated for T2DM during 2018 at non-communicable disease clinics in primary health centers in Bahrain. Cases of 382 patients who underwent abdominal ultrasonography were selected for the study. The collected patients' data were statistically analyzed. Prevalence of NAFLD among T2DM patients and the possible risk factors were assessed.

RESULTS

The mean age of the study population (N = 382) was 59.0±12.0 years. The majority (61.5%) were women. Hypertension (57.9%) was the most prevalent associated condition. Most patients were either overweight (30.5%) or obese (58.3%). Fatty liver was found in 68.1% patients based on ultrasound imaging. Elevated alanine aminotransferase was found in 75 (21.0%) out of 357 (93.5%) patients who were tested for the same. The significant risk factors identified for fatty liver were female ( = 0.013), high body mass index (BMI) ( 0.001), high waist circumference ( = 0.011), and high triglyceride levels ( = 0.043). Binary logistic regression identified BMI as an independent risk factor for fatty liver ( = 0.005).

CONCLUSIONS

The prevalence of NAFLD among patients with T2DM in Bahrain is high, and comparable to the levels reported in other studies. Female and high BMI, waist circumference, and triglyceride level are risk factors for NAFLD, while BMI is an independent risk factor.

摘要

目的

确定巴林2型糖尿病(T2DM)患者中非酒精性脂肪性肝病(NAFLD)的患病率,并评估其危险因素。

方法

这项回顾性横断面研究调查了2018年在巴林初级卫生中心非传染性疾病诊所接受T2DM治疗的患者随机样本。选择了382例接受腹部超声检查的患者进行研究。对收集的患者数据进行统计学分析。评估T2DM患者中NAFLD的患病率及可能的危险因素。

结果

研究人群(N = 382)的平均年龄为59.0±12.0岁。大多数(61.5%)为女性。高血压(57.9%)是最常见的相关疾病。大多数患者超重(30.5%)或肥胖(58.3%)。根据超声成像,68.1%的患者发现有脂肪肝。在357例(93.5%)接受检测的患者中,75例(21.0%)丙氨酸转氨酶升高。确定的脂肪肝显著危险因素为女性(P = 0.013)、高体重指数(BMI)(P < 0.001)、高腰围(P = 0.011)和高甘油三酯水平(P = 0.043)。二元逻辑回归确定BMI是脂肪肝的独立危险因素(P = 0.005)。

结论

巴林T2DM患者中NAFLD的患病率很高,与其他研究报告的水平相当。女性以及高BMI、腰围和甘油三酯水平是NAFLD的危险因素,而BMI是独立危险因素。